Layra Kennya Maia de Oliveira Tavares, Isabel F Cruz


Patients admitted to Intensive Care Units (ICU) need special and continuous attention. Technology has become an essential tool in quality care for patients with diabetes, as it demonstrates good metabolic control and prevents complications. Objective: the objective of this work was to search the professional scientific literature for digital technologies, their characteristics and their purpose of use which can optimize the nursing intervention in insulin administration, as well as have a positive impact on the therapeutic results of (a) high complexity patient. Method: with regard to the methodology, this is a systematic review of the literature carried out in the Virtual Health Library (VHL), from July to October 2021, with the descriptors insulin infusion system, technology, nursing, intensive care and their combinations, in Portuguese, using the Boolean AND operator and the following inclusion criteria: full text, language (Portuguese, English and Spanish), type of document (articles) and publication year range (2013 to 2020) and exclusion criteria: related to the theme and articles repeated in the bases. After the search, selection and analysis of the articles, 10 studies were selected to compose the sample, which were available in full and which were in accordance with the PICOT strategy. Results: CGM devices, associated with the infusion pump, reduce HbA1c more than when pump therapy alone is used, improving the safety and efficacy of diabetes therapy. Conclusion: technological advances, associated with continuing education have improved the management of the disease and also the quality of life of patients who require multiple doses of insulin.


Insulin pump; Intensive Therapy

Full Text:



Turksoy K, Monforti C, Park M, Griffith G, Quinn L. Use of Wearable Sensors and Biometric Variables in an Artificial Pancreas System. Sensors [ Internet] 2017 [cited 2021 ago 27];17(3):532. Available from: https://www.semanticscholar.org/paper/Use-of-Wearable-Sensors-and-Biometric-Variables-in-Turksoy-Monforti/6a62c37f6ae79086f091edb83861442a8cc7e274.

Santos ECB, Galindo Neto NM, Santos ITS, Teixeira CRS, Landim CAP. Bomba de Infusão Contínua em pacientes com Diabetes Mellitus: revisão integrativa. J Nurs UFPE on line [Internet]. 2013 [cited 2021 ago 27];7(5 spe):1570-6. Available from: https://periodicos.ufpe.br/revistas/revistaenfermagem/article/view/11648.

Vettoretti M, Cappon G, Facchinetti A, Sparacino G. Advanced Diabetes management using artificial intelligence and continuous glucose monitoring sensors. Sensors [Internet] 2020 [cited 2021 ago 27];20(14),3870. Available from: https://doi.org/10.3390/s20143870.

Vaquero PM, Brocca MAM, López JMG. Documento de posicionamiento sobre la eficiencia de las tecnologías aplicadas al manejo de la diabetes. Endoc Nutr [Internet].2014 [cited 2021 ago 27];61(10):e45-e63. Available from: https://doi.org/10.1016/j.endonu.2014.08.003.

Cappon G, Vettoretti M, Sparacino G, Facchinetti A. Continuous Glucose Monitoring Sensors for Diabetes Management: a review of technologies and applications. Diabetes Metab J [Internet] 2019 [cited 2021 ago 27];43(4):383-397. Available from: https://doi.org/10.4093/dmj.2019.0121.

Gómez AM, Grizales AM, Veloza A, Marín A, Munoz OM, Rondón MA. Factores asociados con el control glucémico óptimo en pacientes tratados con bomba de insulina y monitorización continua de glucosa en tiempo real. Av Diabetol [Internet]. 2013 [cited 2021 ago 27];29(3):74-80. Available from: https://www.elsevier.es/es-revista-avances-diabetologia-326-pdf-S1134323013000409.

Gomez AM, Cristancho RA, Orozco JJ, Lynch PM, Pietro D, Saunders R, et al. Beneficios clínicos y económicos de la terapia con bomba de insulina integrada a sistema de monitoreo continuo de glucosa en los pacientes diabéticos tipo 1 en Colombia. Endoc Nutr [Internet]. 2016 [cited 2021 ago 27];63(9):466-474. Available from: https://doi.org/10.1016/j.endonu.2016.05.011.

Granadeiro RMA, Sá SPC, Granadeiro DS, Passos JP, Santod FB, Santos MER. Hypoglycemia Minimizing Technologies Used in Adult Patients During Continuous Infusion of Insulin. R Pesq.: cuid fundam Online [Internet]. 2020 [cited 2021 ago 27];12: 897-902. Available from: https://media.proquest.com/media/hms/PFT/1/hopdH?_s=6BKAazvRRnQOIlAVmzJkNekAiCY%3D.

Castle JR, Youssef JE, Wilson LM, Reddy R, Resalat N, Branigan D, et al. Randomized Outpatient Trial of Single-and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors. Diabetes Care [Internet]. 2018 [cited 2021 ago 27];41 (7):1471–1477. Available from: https://care.diabetesjournals.org/content/41/7/1471.

Mader JK, Lilly LC, Aberer F, Poetter T, Johns D, Trautman M, et al. Research: Treatment Improved glycaemic control and treatment satisfaction with a simple wearable 3-day insulin delivery device among people with Type 2 diabetes. Diabet Med [Internet]. 2018 [cited 2021 ago 27];35:1448–1456. Available from: https://www.readcube.com/articles/10.1111%2Fdme.13708.

URN: http://www.jsncare.uff.br/index.php/jsncareurn:nbn:de:1983-4152jsncare.v14i1.34742

Share |